World and Chinese Industrial Enzyme Industry Research Report

2012-11-22
Published : Nov-2012

Industrial enzyme which refers to the enzyme preparation used for industrial purposes can be applied to detergent, animal feed, bread, brewing (beer, wine, etc.), papermaking, textile, bio-ethanol and so forth; especially, food & brewing, feed and detergent are the most commonly application fields, and they consume about 75% of industrial enzyme together.

The industrial enzyme market size has been expanding in recent years with the improvement of R&D technology and the extension of application range. From 2001-2011, the global industrial enzyme market scale presented a CAGR of 6.8%, and in 2011 the global market valued USD3.5 billion, with a year-on-year growth rate of 6.1%. Through numerous mergers and acquisitions, the global industrial enzyme market concentration degree has been gradually raised. In 2011, Novozymes and DuPont (DuPont acquired Genencor) enjoyed market share of 47% and 21% respectively.

Through several decades of development, China has become an important production base of industrial enzyme, and its market size accounts for about 10% of the global size. Judging from Chinese economic situation and domestic demand, the industrial enzyme market of China is expected to embrace a faster growth rate of 10% or so than the global 6%-8% in the next three years, and it will reach at least RMB3 billion in 2014. Yet, foreign tycoons with patent monopoly and strong R&D capabilities have entered China in succession, while Chinese counterparts are lagged in R&D, therefore Chinese native enzyme preparation enterprises have weak competitiveness, and the Chinese market is still currently dominated by Novozymes, DuPont (Genencor) and other foreign brands.

Buy a copy of this report @ http://www.reportsnreports.com/reports/206487-global-and-china-industrial-enzyme-industry-report-2012-2014.html

Published: November 2012
No. of Pages: 68

Price: Single User: US $ 1800       Corporate User: US $ 28000

However, in market segments like feedstuff, Chinese play, VTR, for example, occupy a significant position, with 16.5% share (by sales volume) in Chinese feed enzyme market in 2011. Meanwhile, local enterprises are not only increasing new products, but also striving to expand their production scale and enhance marketing; for instance, VTR invested the funds raised from IPO in “12,000 t/a Enzyme Preparation Project Phase II” in Inner Mongolia (early 2012); Hunan Hongyingxiang and Jinshi Development Zone signed an agreement for “300,000 standard tons/a Enzyme Preparation Project” (May, 2012). Therefore, based on local advantages, it is expected that Chinese companies will sweep more market shares.

The report covers the following:

  • Status quo, regional distribution, competition pattern and prospect of global industrial enzyme industry;
  • Relevant policies, current situation, competitive landscape, import & export and prospect of Chinese industrial enzyme industry;
  • Impact of industrial enzyme downstream sectors like baked food, brewing, feedstuff and bio-ethanol in China;
  • Operation, enzyme preparation business and development prospect of 9 enzyme preparation suppliers at home and abroad (such as Novozymes, DuPont (Genencor), VTR, Youteer, etc.).

Table of Contents

1 Overview of Industrial Enzyme

2 Development of Global Industrial Enzyme Industry
2.1 Status Quo
2.2 Regional Distribution
2.3 Competition Pattern
2.4 Development Prospect

3 Development of China Industrial Enzyme Industry
3.1 Related Policies
3.2 Market
3.3 Competitive Landscape
3.4 Import and Export
3.4.1 Import
3.4.2 Export
3.5 Development Outlook

4 Impact of Downstream on Chinese Enzyme Industry
4.1 Food Industry
4.1.1 Bakery
4.1.2 Condiments
4.2 Brewing Industry
4.2.1 Beer
4.2.2 Wine
4.2.3 Others
4.3 Detergent Industry
4.3 Feedstuff Industry
4.4 Papermaking and Textile Industry
4.4.1 Papermaking Industry
4.4.2 Textile Industry
4.5 Bio-ethanol Industry

5 Major Foreign Companies
5.1 Novozymes
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 R&D Investment
5.1.5 Enzyme Business
5.1.6 Development in China
5.2 Danisco (Genencor)
5.2.1 Profile
5.2.2 Operation
5.2.3 Development in China
5.3 DSM
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.3 Development in China
5.4 AB Enzymes
5.4.1 Profile
5.4.2 Operation
5.4.3 Development in China

6 Major Chinese Suppliers
6.1 Guangdong VTR
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Customers and Suppliers
6.1.5 Capacity, Output and Sales Volume
6.1.6 Costs and Prices
6.1.7 Prospect
6.2 Hunan Youteer
6.2.1 Profile
6.2.2 Operation and Development Forecast
6.3 Shandong Longda
6.3.1 Profile
6.3.2 Operation and Development Forecast
6.4 KDN Biotech
6.4.1 Profile
6.4.2 Operation and Development Forecast
6.5 Sunson
6.5.1 Profile
6.5.2 Operation and Development Forecast

Selected Charts in this Report:

  • Global Industrial Enzyme Market Size and YoY Growth Rate, 2008-2011
  • Global Industrial Enzyme Market Structure (by Application)
  • Regional Distribution of Global Enzyme Preparation, 2011
  • Market Share of Global Industrial Enzyme Enterprises, 2011
  • Global Industrial Enzyme Market Size, 2011-2014E
  • Major Enzyme Enterprises and Their Competitive Edges in China
  • Enzyme Import Volume and Value in China, 2009-2012
  • Average Enzyme Import Price in China, 2009-2012
  • Enzyme Import Volume (by type) in China, Jan.-Aug. 2012
  • Enzyme Import Volume and Value (by Country and Region) in China, Jan.-Aug. 2012
  • Enzyme Export Volume and Value in China, 2009-2012
  • Average Enzyme  Export Price in China, 2009-2012
  • Enzyme Export Volume and Value (by Country and Region) in China, Jan.-Aug. 2012
  • Some New Industrial Enzyme Projects in China, by Aug. 2012
  • Pastry Output and YoY Growth Rate in China, 2007-2011
  • Revenue and Total Profit of Chinese Bakery Industry, 2008-2012
  • Revenue and Total Profit of China’s Condiment and Fermentation Products Industry, 2008-2012
  • Soy Sauce Output and YoY Growth Rate in China, 2007-2012
  • Application of Enzyme Products in Beer Brewing
  • Beer Output and YoY Growth Rate in China, 2007-2012
  • Beer Sales Volume and Sales-output Ratio in China, 2007-2012
  • Revenue and Total Profit of China Beer Industry, 2008-2012
  • Wine Output and YoY Growth Rate in China, 2007-2012
  • Revenue and Total Profit of China Wine Industry, 2007-2012
  • Detergent Output in China, 2007-2012
  • Feedstuff Output (by Type) in China, 2011
  • Feedstuff Output (by Category) in China, 2011
  • Output of Pulp, Machine-made Paper and Paperboard in China, 2007-2012
  • Revenue of Pulp, Machine-made Paper and Paperboard in China, 2007-2012
  • Output of Cloth, Yarn and Silk Fabrics in China, 2008-2012
  • Revenue of China Textile Industry, 2007-2012
  • Revenue and EBIT of Novozymes, 2007-2011
  • Investment Funds and ROIC of Novozymes, 2007-2011
  • Revenue of Novozymes (by Applicantion),  2011
  • Revenue of Novozymes (by Region) , 2011
  • R&D Investment and Its Proportion in Revenue of Novozymes, 2007-2011
  • Industrial Enzyme Revenue of Novozymes (by Product) , 2007-2011
  • Danisco’s Companies in China
  • DSM’s Revenue and Operating Profit, 2010-2011
  • DSM’s Revenue (by Business), 2010-2011
  • DSM’s Revenue (by Application), 2010-2011
  • DSM’s Revenue (by Origin), 2010-2011
  • DSM’s Revenue (by Sales Region), 2010-2011
  • Revenue and Profit of ABF Additive Business, 2009-2011
  • VTR’s Revenue and Profit , 2009-2011
  • VTR’s Enzyme Preparation Revenue (by Product or Dosage Form), 2009-2011
  • VTR’s Revenue (by Sales Model) , 2009-2011
  • Namelist and Revenue Contribution of VTR’s Top 5 Clients, 2009-2011
  • Name list and Procurement of VTR’s Top 5 Suppliers, 2009-2011
  • VTR’s Enzyme Preparation Output (by Base), 2009-2011
  • VTR’s Enzyme Preparation Capacity, Output and Sales Volume (by Dosage Form), 2009-2011
  • VTR’s Enzyme Preparation Output and Sales Volume (by Product), 2009-2011
  • Procurement Quantity and Price of VTR’s Raw Materials, 2009-2011
  • Quantity and Proportion of VTR’s Self-produced and Purchased Enzyme Sources, 2009-2011
  • VTR’s Raw Material Procurement Capital and Proportion, 2009-2011
  • VTR’s Enzyme Preparation Price (by Product or Dosage Form), 2009-2011
  • VTR’s Product R&D Progress, by end 2011
  • VTR’s R&D Cost and % in Revenue, 2009-2011
  • VTR’s IPO Projects and Funds, 2012
  • VTR’s Revenue and Net Income, 2011-2014E
  • Revenue and Net Income of Hunan Youteer, 2008-2011
  • Revenue and Net Income of Hunan Youteer, 2011-2014E
  • Events of KDN Biotech, 2011-2012
  • Sunson’s R&D Centers and Production Bases
  • Operating Revenue and Operating Income of Sunson, 2008-2009
Filed in: Biotechnology
More Reports
Title Price Buy Now

Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027

“The stem cell assays market growth can be attributed to factors such as the rising demand for technologically advanced stem cell analysis instruments, increase in the prevalence of cancer & other diseases and rising number of biopharma and & biotechnology companies working on stem cell based therapies.” The stem cell assays market is projected to reach USD 4.5 Billion by 2027 from USD 1.9 Billion in 2022, at a CAGR of 17.7% during the forecast period. The growth of the market is projected to be driven by collaborations and agreements among market players for stem cell assay products & services, launch of new stem cell analysis systems such as flow cytometers and increase in R&D expenditure by biopharmaceutical and biotechnology companies. The viability/cytotoxici......
 $

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027

The nucleic acid isolation and purification market is expected to grow at a CAGR of 7.9% in the forecast period. The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market. As the world be......
 $4950

Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027

“Rising number of road accidents and associated traumatic wounds and growing incidence of burn injuries are driving the overall growth of the wound care biologics market” The global wound care biologics market is valued at an estimated USD 1.8 billion in 2022 and is projected to reach USD 2.4 billion by 2027, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the growing incidence of burn injuries and the rising number of road accidents and associated traumatic wounds. However, the high cost of wound care biologic products and the risk associated with skin substitute failure are the major factors hampering the growth of this market. “The biological skin substitutes segment accounted for the highest growth rate in the wound care biologics ma......
 $4950

Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) – Global Forecast to 2027

“The global bioanalytical testing services market is projected to grow at a CAGR of 15.6%” Bioanalytical testing involves analytical methods used for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services market is projected to reach USD 6.0 billion by 2027 from an estimated USD 2.9 billion in 2022, at a CAGR of 15.6% during the forecast period. “The Cell-based assays segment is expected to account for the largest share of the bioanalytical testing services market” The increasing prevalence of chronic diseases and the rising number of clinical trials ar......
 $4950

Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) – Global Forecast to 2027

“Single-cell analysis segment has gained significant traction in the recent years attributed to the widening applications of this technology in cancer research. This is further supplemented by the robust government initiatives targeted towards single-cell analysis research. The growth of the single-cell analysis segment is expected to drive the overall growth of the cell analysis market.” The global cell analysis market is projected to reach USD 28.6 Billion by 2027 from USD 17.7 Billion in 2022, at a CAGR of 10.1% during the forecast period. Key opportunities for the cell analysis market include, emerging economies, high risk of communicable diseases and pandemic outbreak, and increasing adoption of novel cellular assays in various cancer research applications. On the other hand, h......
 $4950

3D Cell Culture Market by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region – Global Forecast to 2027

“Increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine is driving the overall growth of the3D Cell culture market” The global 3D cell culture market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6% during the forecast period. The growth of this market is mainly driven by factors such as the increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, a lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the f......
 $4950

Tangential Flow Filtration Market by Product (System, Membrane Filter), Material (PES, PVDF, PTFE), Technique (Ultrafiltration), Application (Final Product Processing, Raw Material Filtration), End User (Pharma, Biotech), Region – Global Forecast to 2027

“Growth in the tangential flow filtration market can be attributed to factors such as the growing advantages of tangential flow filtration over normal flow filtration, rising R&D spending in pharmaceutical & biotechnology industries and increasing adoption of single-use technologies.” The global tangential flow filtration market is projected to USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.2% during the forecast period. The rising advantages of tangential flow filtration over normal flow filtration, increasing adoption of single-use technologies, and growing R&D spending in pharma-biotech companies. On the contrary, the high capital investments for setting up new production facilities are expected to restrain the market growth. “In 2021 the s......
 $4950

Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) – Global Forecast to 2029

“Increased focus on human microbiome therapy development to drive the growth of this market.” The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth. However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market's growth. “By product segment, the drugs segment accounted for the largest share of huma......
 $4950

Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User – Global Forecast to 2026

“Increasing interest in exosome-based proceduresto Drive the Growth of Market” The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. “By product & service, the kits & reagents segment accounted for the largest share of the exosome research market” Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other ki......
 $4950

Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) – Global Forecast to 2027

“Continuous technological innovations in NGS platforms is the key factors driving growth in the metagenomic sequencing market’’ The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period. Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields. “By technology segment, the shotgun metagenomic sequencing segment accounted for the fastest-growing segment of the metagenomic sequencing market” Based on technol......
 $4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy